天然药物化学第二讲课件

上传人:文**** 文档编号:182416096 上传时间:2023-01-23 格式:PPT 页数:69 大小:4.52MB
收藏 版权申诉 举报 下载
天然药物化学第二讲课件_第1页
第1页 / 共69页
天然药物化学第二讲课件_第2页
第2页 / 共69页
天然药物化学第二讲课件_第3页
第3页 / 共69页
资源描述:

《天然药物化学第二讲课件》由会员分享,可在线阅读,更多相关《天然药物化学第二讲课件(69页珍藏版)》请在装配图网上搜索。

1、Introduction to the Studies of Biosynthesis of Natural Products Yuemao SCollege of Pharmaceutical Sciences,Shandong UniversitySeptember 13,20103.Three examplesThe Biosynthesis of TaxolTechniques we applied:A.Stable isotope labeling,feedingB.Radioactive isotope tracing in Enzymatic acetylation Conclu

2、sion:10-deacetylbaccatin-III is a precursor of taxol02000400060008000CPM05101520Retention time,min Figure B-210g Of 10-deacetylbaccatin-III incubated with 1Ci of 3H-acetyl-CoA plus100nmole unlabeled acetyl-CoA and 300l of crude cell free extract fromTaxus media cell cultures collected on the 5th day

3、 and 7th day,respectively.300ul of boiled 7th days crude cell free extract300ul of 7th days crude cell-free extract300ul of boiled 5th days crude cell-free extract300ul of 5th dayscrude cell-free extractbaccatin-IIIHPLC conditions:Solvents:A.H2O;B.AcetonitrileFlow rate:1ml/minGradient:(T min,B%),(0,

4、40),(5,40),(15,70)UV detection at 230nmHypothetic multiple pathways towards taxolAcOOHOHAcOOOONHOHOOOBzAcOOHOHAcOOOHOOBzTaxolBaccatin-IIIHOOHOHAcOOOONHOHOOOBzHOOHOHAcOOOHO10-DeacetyltaxolOBz10-Deacetylbaccatin-IIIABABThe biosynthesis of rifamycin BTwo possible pathways,A and B,towards rifamycin B.A

5、demanded that protorifamycin I is the key intermediate and the oxygen at the C-8 position is introduced later.B required that the oxygen at C-8 is of the same origin as the carbon of C-8,i.e.,from the carboxyl group of AHBA.OHH3COOCH2CO2HNHOHOHOHCH3CH3OOCH3CH3CH3CH3CH3COOCH3OOOHNH2OOOH OH OH OHEnzSO

6、OHNHOHOHOHOHOOOOHOOHNHOHOHOHOHOOOOHOOHABrifamycin B 8x propionate 2x acetateprotorifamycin Iproansamycin Xrif PKSs888C.6HOONH2OHAHBA+Methods and Techiques:DNA mutagensis;stable isotope labeling,feeding;13C NMR assay;LC-ESI-MSConclusions:A.The C-8 oxygen is the same origin as the C-8 carbonB.The form

7、ation of naphthoquinone precedes the lactamizationC.The biosynthesis of type I polyketides occurs progressivelyThe sequence of the formation of the naphthoquinone and lactamEnz-SOHOHOHOHNH2OHOHOONH2OHOHOOtype I PKSsThe mutant HGF010,in which the genes from rifF to rifN and part of rifE were deleted.

8、Upon feeding AHBA,this mutant should produce C.15 or related compounds.rifArifBrifCrifDrifEC.15PEP+E4PrifG,rifH,rifI,rifK,rifL,rifM,rifNAHBA(3-amino-5-hydroxybenzoic acid)rifA,rifB,rifC,rifD,rifErifFOHOHOHOHNH2OHOHOONH2OHOHOOEnz-SOONH2HOOOHOHOHOHHOOtype I PKSsThe mutant HGF018,in which the rifF gene

9、 was deleted,thus it might accumulate C.10 or C.10a or related compounds.rifArifBrifCrifDrifEC.10PEP+E4PrifG,rifH,rifI,rifK,rifL,rifM,rifNAHBA(3-amino-5-hydroxybenzoic acid)rifA,rifB,rifC,rifD,rifEC.10arifFOONH2MeOMeOOOOHNH2OHOOHOOONH2HOHOOOSY5OHNHOHOOHOCHOOHNHOHOOHOCCH3OOONH2HOOOOHOOONH2HOOOHHOOOON

10、H2HOOOOHOHOHOOONH2HOOOHOHOHHOOOONH2HOHOOOOHOHOHOHSY4aSY4b16111517SY5SY41816111517123456789124356123456789124356123456789124356SY7SY618201111171919212421SY9SY822241111212323253027SY101324567891011131517192123252627282930313218The structures of new polyketides from the HGF018 mutant(Scheme C-10).C.16C

11、.17C.18C.19C.19C.20C.22C.21C.23C.25type I PKSsrifArifBrifCrifDrifEPEP+E4PrifG,rifH,rifI,rifK,rifL,rifM,rifNNH2OHOHOAHBA(3-amino-5-hydroxybenzoic acid)rifA,rifB,rifC,rifD,rifEOONH2HOOOHOHOHOHHOOC.27rifFOONH2HOOOHOHOHOHHOOC.26OHOONH2HOOOONH2HOOOHH+SY5-10The suspected conversion of the original compoun

12、ds produced by the HGF018 mutan to SY5-10 by dehydration during workup.C.28C.29Table 5 Ions selected in LC-ESI-MS analysis for the methanol extract of the HGF018 mutant.280b SY4 (Scheme C-12)298 P8/1-OG(Scheme C-11)320a SY4a (Scheme C-12)334a SY4b (Scheme C-12)344a SY5 (Scheme C-12)372 SY5a(Scheme C

13、-16)362 SY5b (Scheme C-17)390 SY5c (Scheme C-18)402a SY6 (Scheme C-12)430 SY6a (Scheme C-16)420 SY6b (Scheme C-17)448 SY6c (Scheme C-18)442a SY7 (Scheme C-12)470 SY7a (Scheme C-16)460c SY7b (Scheme C-17)SY7 (Scheme C-17)488 SY7c (Scheme C-18)518a SY8 (Scheme C-12)500b SY8 (Scheme C-17)546 SY8a (Sche

14、me C-16)536 SY8b (Scheme C-17)564 SY8c (Scheme C-18)558a SY9 (Scheme C-12)586 SY9a (Scheme C-16)576c SY9b (Scheme C-17)SY9 (Scheme C-17)604 SY9c (Scheme C-18)602a SY10 (Scheme C-12)630 SY10a (Scheme C-16)620 SY10b(Scheme C-17)648 SY10c (Scheme C-18)642 C.26 (Scheme C-13)670 C.26a (Scheme C-14)684 C.

15、26b (Scheme C-14)660 C.27 (Scheme C-13)688b SY11a(Scheme C-14)702 C.27b (Scheme C-14)662 C.28 (Scheme C-13)666 C.29 (Scheme C-13)650 C.30 (Scheme C-13)a.Detected by LC-ESI-MS in the HGF010 and HGF018 mutant,and isolated from the HGF018mutant.b.Only detected by LC-ESI-MS in the HGF018 mutant.c.Each h

16、as two candidate structures,SY7b and SY7,and SY9b and SY9,respctively.Accordingto the retention time of respective peak in HPLC,the two compounds detected in this experimentwere SY7 and SY9 rather than SY7b and SY9b.OHH3COOCH2CO2HNHOHOHOHCH3CH3OOCH3CH3CH3CH3CH3COOCH3OOOHNH2OOOHOHOHOHEnzSOOHNHOHOHOHO

17、HOOOOHOOHNHOHOHOHOHOOOOHOOHrifamycin B AHBA 8x propionate 2x acetateprotorifamycin Iproansamycin Xrif PKSs888C.6ABPathway B is correctOHH3COOCH2CO2HNHOHOHOHCH3CH3OOCH3CH3CH3CH3CH3COOCH3OORifamycin BThe rifamycin B biosynthetic pathway deduced from the chemical data obtained from the studies on the c

18、omponents accumulated by the HGF018 mutant and the feeding experiment in the HGF003 mutant.PEP+E4PNH2OHOHOAHBA(3-amino-5-hydroxybenzoic acid)amide synthaseProansamycin XNHOHOHOHOHOOOOHOOHOONH2HOOOHOHOHOHACP-SOOHPKSsA speculative structure only its formamide was likely detected by LC-ESI-MS in the HG

19、F018 mutantA speculative structureSNH2HOOHOOSNH2HOOHOSNH2HOOOOHOSOOOHOHOHOHOOHOSOOHOHOHOHOOOHOSOOHOHOHOHOOOHOSOOHOHOHOOOHOSOOHOHOOOHOSOOHOOOHOSOOSNH2HOOHOOO Scheme C-20Scheme of rifPKS showing functional domains in the five-component polyketides,and scheme of acyl chain growth showing structures as

20、ACP thioester at the end of each condensation/reduction cycle.Modules are shown to indicate component functions.Scheme of processive syntheses of rif polyketides.showing the formation of naphthoquinonebetween tetraketide and pentaketide(see Scheme C-15 for detailed information about the proposed mec

21、hanism of this transformation).Ten polyketides should be produced by rifPKS,among them,SY4a-10 have been isolated by the author.Their structures were elucidatedon the bases of 1D and 2D NMR spectra.Starter unit,AHBA is coded with pink.Polyketide extension units are coded with deep blue.Abbreviations

22、:ACP,acyl carrier protein;AT,acyltransferase;DH,dehydratase;KS,-ketoacyl ACP synthase;KR,-ketoreductase;DH,KR,nonfunctional DH and KR domain.After selecting AHBA as stater unit,the procedures of the biosynthesis of rif polyketide can be classified to three phases:Stage A,B and C.NH2NH2OHOHOHNH2NH2OH

23、OHNH2OHNH2OHNH2OOHOOOHOOOHNH2ONH2NH2HOOH KS AT DH KR ACP KS AT ACP KS AT DH KR ACPKS AT DH KR ACP KS AT KR ACP KS AT DH KR ACPKS AT KR ACPKS AT DH KR ACPKS AT DH KR ACP KS AT DH KR ACPAT ACPSY5SY6SY7SY8SY9SY10SY11aSY4aSY4bDehydrationSY4Acylation orLactonizationAcylationOHStage BThe releasement of in

24、termediates under the action of the editingfunction of thioesteraseStage CModificationsproductsintermediatesStage AThe assembly ofpolyketide chainThe biosynthesis of Streptomyces spore pigmentPlasmid constructions and resulting polyketide productsplasmid genes productspIJ4293 whiE-ORFIII,-ORFIV,-ORF

25、V TW93a,TW93b,TW93c,TW93d,TW93e,TW93f,TW93g,TW93hpIJ4294 whiE-ORFIII,-ORFIV,-ORFV,actIII TW94a,TW94b,TW94c,TW94dpIJ4295 whiE-ORFIII,-ORFIV,-ORFV,-ORFVI TW95a,TW95bpIJ4296 whiE-ORFIII,-ORFIV,-ORFV,-ORFVI,-ORFVII TW95a,TW95bpIJ4297 whiE-ORFII,-ORFIII,-ORFIV,-ORFV TW93a,TW93b,TW93c,TW93d,TW93e,TW93f,TW

26、93g,TW93hpIJ4298 whiE-ORFII,-ORFIII,-ORFIV,-ORFV,-ORFVI TW95a,TW95bpIJ4300 whiE-ORFII,-ORFIII,-ORFIV,-ORFV,-ORFVI,-ORFVII Blue pigment(not identified)pIJ4301 sch1,sch2,sch3 TW93a,TW93b,TW93c,TW93d,TW93e,TW93f,TW93g,TW93hpIJ4302 sch1,sch2,sch3,actIII TW94a,TW94b,TW94c,TW94dpIJ4303 curA,curB,curC TW93

27、a,TW93b,TW93c,TW93d,TW93e,TW93f,TW93g,TW93hpIJ4304 curA,curB,curC,actIII TW94a,TW94b,TW94c,TW94dpIJ4305 curA,curB,curC,curF,curG TW95a,TW95bOOHOHOHOOOHOHOHO222497O22OOHOO2272OOOHOHTW94cTW94bTW94dTW94aOrigins of Building BlocksCommon Building BlocksC1C2C5Common Building BlocksC6C3C6C2C6C1C6C2NCommon

28、Building BlocksC4NC5NIndole-C2NCommon FAsAcyl ThioesterGeneral ChemistryAldol and Claisen CondensationAldol and Claisen CondensationAldol and Claisen CondensationMalonyl CoA:activated acetyl CoAMalonyl CoA:activated acetyl CoAOverall Biosynthetic SchemeHOOCSCoAOHOOCS-ACPORS-CoAORS-KSORS-ACPOORROOOOO

29、HnROHOnATKSKRDHERCO2CondensationABCDKetoReductionDehydrationEnoylReductionFatty acidReduced polyketidePolyketideAcyl transferFatty acid synthase(FAS)and Polyketide synthase(PKS)KS=Beta-ketoacyl synthase KR=Beta-ketoacyl reductase ACP=Acyl carrier proteinAT=Acyl transferase DH=Dehydratase ER=Enoyl re

30、ductase TE=ThioesteraseTEROROACPStarter unitExtension unit+ATRS-ACPOHORS-ACPORS-ACPOTEKSBacterial Aromatic PolyketidesBacterial Aromatic PolyketidesBacterial Aromatic PolyketidesBacterial Reduced PolyketidesA,Acetate;P,Propionate;B,Butyrate;G,Glycerol;S,Starter from branched chain or cyclic unitsBac

31、terial Reduced PolyketidesBacterial Reduced PolyketidesFungal Aromatic Polyketides(Non-reduced/Partially Reduced Polyketides)Orsellinic acidTetrahydroxynaphthalene(THN)6-Methylsalicylic acid(MSA)Norsolorinic acidFungal Aromatic Polyketideswith unusual features-mixed reduced/non-reducedUnusual acetat

32、e labelUnusual starterUnusual mixFungal Highly Reduced PolyketidesT-toxinMevacorStatins hydroxy-methylglutaryl-CoA(HMG-CoA).Fungal Aromatic Polyketides(Non-reduced/Partially Reduced Polyketides)Orsellinic acidTetrahydroxynaphthalene(THN)6-Methylsalicylic acid(MSA)Norsolorinic acidPlant Polyketides(B

33、acterial polyketides made by the same type of PKS)chalcone in higher plants 1,3,6,8-tetrahydroxynaphthalene(THN)in Streptomyces griseus and S.coelicolor 3,5-dihydroxyphenylacetic acid(DHPA)in Amycolatopsis mediterranei and A.orientalis Plant Polyketides(Starter:Phenylpropanhoid Pathway)chalconePlant

34、 Polyketides(Bacterial polyketides made by the same type of PKS)chalcone in higher plants 1,3,6,8-tetrahydroxynaphthalene(THN)in Streptomyces griseus and S.coelicolor 3,5-dihydroxyphenylacetic acid(DHPA)in Amycolatopsis mediterranei and A.orientalis Nonribosomal PeptidesAntibioticsNonribosomal Pepti

35、desAntibioticsNonribosomal PeptidesImmunosuppresantsNonribosomal PeptidesToxinsNonribosomal PeptidesNonribosomal PeptidesNonribosomal PeptidesNonribosomal PeptidesNonribosomal PeptidesNonribosomal PeptidesAntibioticsNonribosomal PeptidesAntibioticsNonribosomal PeptidesLast resort for against drug-resistant pathogens Nonribosomal PeptidesHybrid NRP-PK Nonribosomal PeptidesHybrid NRP-PK-C-aminated Nonribosomal PeptidesHybrid NRP-PK-N-acylatedNonribosomal Peptides

展开阅读全文
温馨提示:
1: 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
2: 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
3.本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
5. 装配图网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
关于我们 - 网站声明 - 网站地图 - 资源地图 - 友情链接 - 网站客服 - 联系我们

copyright@ 2023-2025  zhuangpeitu.com 装配图网版权所有   联系电话:18123376007

备案号:ICP2024067431-1 川公网安备51140202000466号


本站为文档C2C交易模式,即用户上传的文档直接被用户下载,本站只是中间服务平台,本站所有文档下载所得的收益归上传人(含作者)所有。装配图网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。若文档所含内容侵犯了您的版权或隐私,请立即通知装配图网,我们立即给予删除!